Reata Pharmaceuticals, Inc.
USD172.36
+0.04 (+0.02%)
CEO
J. Warren Huff
IPO Date
2016-05-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$172.34
Prev. Close
$172.32
Day Low
$172.32
Day High
$172.46
52W Low
$21.83
52W High
$172.46
Market Cap
$6.57B
Volume
1.91M
| -3.2 |
| 31 Dec 2020 | FY | 100.0% | -2747.0% | 25.9% | -28.9% | 0.00 | 7.11 | -16.8 |
| 31 Dec 2019 | FY | -369.1% | -1094.3% | 40.8% | -42.5% | -0.22 | 3.49 | -21.4 |
| 31 Dec 2018 | FY | 100.0% | -150.3% | 19.2% | -23.3% | -0.19 | 6.12 | -19.3 |
| 31 Dec 2017 | FY | 100.0% | -99.2% | 14.1% | -35.2% | -0.06 | 2.80 | -14.2 |
| 31 Dec 2016 | FY | 100.0% | -12.5% | 2.2% | -7.0% | 0.00 | 1.46 | -69.5 |
| 31 Dec 2015 | FY | 100.0% | -2.9% | 0.5% | -1.8% | 0.00 | 1.27 | -49.6 |
| 31 Dec 2014 | FY | 100.0% | 1.3% | -0.3% | 0.5% | 0.00 | 1.84 | 104.3 |
| 31 Dec 2013 | FY | 100.0% | -68.6% | 12.7% | -15.3% | 0.00 | 1.67 | -2.0 |
| -7.6 |
| 31 Dec 2022 | Q4 | 100.0% | -9354.7% | 130.1% | -16.6% | -1.82 | 6.75 | -4.0 |
| 30 Sept 2022 | Q3 | 100.0% | -14220.6% | -1700.4% | -13.2% | 31.16 | 8.78 | -3.0 |
| 30 Jun 2022 | Q2 | 100.0% | -9652.9% | 5.2% | -11.6% | -0.11 | 10.60 | -3.8 |
| 31 Mar 2022 | Q1 | 100.0% | -8079.0% | -57.8% | -10.9% | 1.11 | 12.32 | -4.0 |
| 31 Dec 2021 | Q4 | 100.0% | -9141.9% | 6.8% | -11.6% | -0.11 | 11.05 | -2.8 |
| 30 Sept 2021 | Q3 | 100.0% | -972.1% | -28.1% | -9.8% | 0.00 | 5.95 | -12.7 |
| 30 Jun 2021 | Q2 | 100.0% | -3273.3% | -23.2% | -9.3% | 0.00 | 6.34 | -17.7 |
| 31 Mar 2021 | Q1 | 100.0% | -7145.7% | -18.3% | -8.3% | 0.00 | 7.04 | -13.4 |